Javier Cortes News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Richard Kellen

Richard L. Kellen, 77, of Aurora, passed away Thursday, February 5, 2015 at his home surrounded by his loving family. He was born September 6, 1937 in Auror

United statesRichardl kellenDolores hettinger kellenBrandon coppDarrell pittmanCarole elsnerSusan jungels kellenFrank betty hettingerRita james crimminsMary morehouseThomas marion hettingerPeter ruthanne hettingerSteve mcmasterKaren mcmasterJon greinerNancy javier cortes kellen

Drug breakthrough could benefit those with common breast cancer

Treating patients who have a common form of breast cancer with immunotherapy, as well as chemotherapy, before and after surgery could be effective.

United kingdomBruxelles capitaleComunidad autonoma de catalunaInstitut jules bordetJavier cortesSimon vincentMichail ignatiadisNational instituteInternational breast cancer centreCancer research united kingdomProfessor javier cortesCare excellenceBreast cancer nowEuropean breast cancer conferenceProfessor michail ignatiadis

Strategy may enable some patients with HER2-positive breast cancer to avoid chemotherapy

Strategy may enable some patients with HER2-positive breast cancer to avoid chemotherapy
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesDaiichi sankyoJavier cortesJavier cortBydevin mclaughlinEli lillyDevin mclaughlinInternational breast cancer centerNektar therapeuticsMerck sharpUniversidad europea de madrid

De-Escalation of Therapy Remains a Focus for Early-Stage HER2+ Breast Cancer

Francisco Javier Esteva, MD, PhD, discusses the management of early-stage HER2-positive breast cancer with a focus on de-escalation strategies, emphasizes the ongoing efforts to de-escalate chemotherapy without compromising effective treatments, and expands on the ongoing debate regarding the role of carboplatin in this setting.

Lenox hill hospitalNew yorkUnited statesFrancisco javier estevaJavier cortesDivision of hematology oncologyBreast medical oncologyNorthwell healthHer2 positive breast cancerDe escalation strategiesEarly stage

Payer Perspectives on SERDs

Dr Langer explores how payers think about the authorization process for DEXA scans and other surveillance activities that would be required for selective estrogen receptor degraders (SERDs) and how oral SERDs affect quality of life.

Lucyr langerJanice luRyan haumschildJavier cortesEnhancing oncology modelEstrogen receptors degradersEr her2 metastatic breast cancerPayers and providersSurveillance activitiesQuality of life